EDITORIAL
Published on 10 Dec 2021
Editorial: Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy With Biologics
doi 10.3389/fphar.2021.815656
- 803 views
- Frontiers in Pharmacology
- Inflammation Pharmacology
- Research Topics
- Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy with Biologics
Autoimmune and Inflammatory Rheumatic Diseases: Identifying Biomarkers of Response to Therapy with Biologics
15k
Total Downloads
52k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 04 Nov 2021
Cardiometabolic Comorbidities in Patients With Psoriasis: Focusing on Risk, Biological Therapy, and Pathogenesis
doi 10.3389/fphar.2021.774808
- 4,948 views
- 22 citations
ORIGINAL RESEARCH
Published on 17 Sep 2021
The Functional Roles of RNAs Cargoes Released by Neutrophil-Derived Exosomes in Dermatomyositis
doi 10.3389/fphar.2021.727901
- 2,606 views
- 10 citations
REVIEW
Published on 15 Jun 2021
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis
doi 10.3389/fphar.2021.672515
- 5,812 views
- 22 citations
ORIGINAL RESEARCH
Published on 24 May 2021
Single Cell RNA-Seq Analysis Identifies Differentially Expressed Genes of Treg Cell in Early Treatment-Naive Rheumatoid Arthritis By Arsenic Trioxide
doi 10.3389/fphar.2021.656124
- 3,896 views
- 4 citations
ORIGINAL RESEARCH
Published on 21 May 2021
Characterization of B- and T-Cell Compartment and B-Cell Related Factors Belonging to the TNF/TNFR Superfamily in Patients With Clinically Active Systemic Lupus Erythematosus: Baseline BAFF Serum Levels Are the Strongest Predictor of Response to Belimumab after Twelve Months of Therapy
doi 10.3389/fphar.2021.666971
- 3,109 views
- 8 citations
SYSTEMATIC REVIEW
Published on 26 Apr 2021
Efficacy and Safety of Adalimumab in Noninfectious Uveitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
doi 10.3389/fphar.2021.673984
- 3,272 views
- 10 citations
ORIGINAL RESEARCH
Published on 16 Mar 2021
The Efficacy of Tocilizumab in the Treatment of Patients with Refractory Immune-Mediated Necrotizing Myopathies: An Open-Label Pilot Study
doi 10.3389/fphar.2021.635654
- 5,169 views
- 25 citations
REVIEW
Published on 16 Mar 2021
Research Progress of Therapeutic Enzymes and Their Derivatives: Based on Herbal Medicinal Products in Rheumatoid Arthritis
doi 10.3389/fphar.2021.626342
- 3,964 views
- 3 citations
CLINICAL TRIAL
Published on 18 Feb 2021
Modeling and Simulation to Support Phase Ib/IIa Dose Selection for WBP216, A Long Half-Life Fully Human Monoclonal Antibody Against Interleukin-6
doi 10.3389/fphar.2021.617265
- 3,425 views
- 1 citation
REVIEW
Published on 02 Feb 2021
Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
doi 10.3389/fphar.2020.635823
- 5,458 views
- 13 citations
ORIGINAL RESEARCH
Published on 24 Nov 2020
Regional Differences in the Gut Microbiota and Gut-Associated Immunologic Factors in the Ileum and Cecum of Rats With Collagen-Induced Arthritis
doi 10.3389/fphar.2020.587534
- 2,623 views
- 14 citations
Published in
Frontiers in Pharmacology
- Inflammation Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Impact
- 52kTopic views
- 34kArticle views
- 15kArticle downloads